Publications by authors named "Mio Namba"

Claim this Profile
R
Release rate is a key variable affecting the therapeutic effectiveness of liposomal fasudil for the treatment of cerebral ischemia/reperfusion injury.
Yosuke Yanagida, Mio Namba, Tatsuya Fukuta, Hirokazu Yamamoto, Mitsuaki Yanagida

Biochem Biophys Res Commun· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke.
Tatsuya Fukuta, Tomohiro Asai, Yosuke Yanagida, Mio Namba, Hiroyuki Koide

FASEB J· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroprotection against cerebral ischemia/reperfusion injury by intravenous administration of liposomal fasudil.
Tatsuya Fukuta, Tomohiro Asai, Akihiko Sato, Mio Namba, Yosuke Yanagida

Int J Pharm· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple basal cell carcinomas in an atomic bomb survivor.
Mio Namba, Nobukazu Hayashi, Yuko Takenaka, Makoto Kawashima

Int J Dermatol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib-induced erythema multiforme: three cases.
Mio Namba, Yuichiro Tsunemi, Makoto Kawashima

Eur J Dermatol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis